Smart Syringes Market Forecast Emphasizing Increasing Adoption in Hospitals Clinics and Public Health Programs to Reduce Needlestick Injuries

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Smart Syringes Market- (By Product (With Needle (Fixed, Exchangeable), Without Needle Bioalcohols), By Volume (Below 1000 μL, Above 1000 μL), By Application (Medical (Drug Delivery, Blood Sample Collection, Vaccination), Non -Medical use )), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

The Smart Syringes Market Size is valued at USD 67.29 Mn in 2023 and is predicted to reach USD 145.62 Mn by the year 2031 at a 10.21% CAGR during the forecast period for 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2010

Smart syringes represent advanced medical injection devices featuring automatic inactivation mechanisms designed to substantially reduce the incidence of needlestick injuries and mitigate the risk of transmission of blood-borne pathogens, including hepatitis B, hepatitis C, and HIV. These devices are increasingly utilized across diverse clinical applications, such as large-scale immunization campaigns, routine therapeutic drug administration, and diagnostic blood collection. The rising prevalence of infectious diseases globally, coupled with the expansion of vaccination programs, is expected to drive sustained growth in the adoption of smart syringe technologies over the forecast period.

Furthermore, heightened emphasis on reducing hospital-acquired infections and enhancing overall healthcare safety protocols is accelerating the transition toward safer injection systems. The growing elderly population, which is more susceptible to infections due to age-related immune decline, further supports demand for secure and reliable injection solutions.

In addition, increasing awareness of occupational hazards within healthcare settings-particularly the rising frequency of needlestick injuries among medical personnel-is shaping market dynamics. Given the significant risks associated with potential disease transmission, healthcare institutions in both developed and emerging regions are prioritizing the integration of smart syringes to improve workplace safety and elevate standards of patient care.

List of Prominent Players in the Smart Syringes Market:
• Becton, Dickinson and Co.
• B. Braun Melungeon AG
• Terumo Medical Corporation
• Baxter International, Inc
• Retractable Technologies, Inc
• Smith's Group Plc
• Merck & Company Inc.
• Medtronic Plc (Covidien)
• Unilife Corporation
• Revolutions Medical Corporation
• AdvaCare Pharma
• Cardinal Health
• Parker Hannifin Corp.
• Numedico Technologies Pty Ltd
• Thomas Scientific (U.S),
• McKesson Medical-Surgical Inc. (U.S)
• Sharps Technology Inc.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics: Smart Syringes
Drivers:
The growing adoption of minimally invasive medical procedures is a key factor driving demand for smart syringes. These devices are designed with integrated safety mechanisms that significantly reduce the risk of needlestick injuries and the transmission of blood-borne infections, including HIV and hepatitis B and C. Their utilization across various clinical applications-such as therapeutic drug administration, diagnostic blood collection, and large-scale immunization programs-continues to strengthen market growth.

Endorsements and guidelines from global health authorities, including the World Health Organization (WHO), have further accelerated adoption by emphasizing safe injection practices in healthcare settings. Additionally, the heightened healthcare activity observed during the COVID-19 pandemic, particularly in pediatric care, contributed to increased deployment of smart syringes. Government-supported vaccination initiatives targeting high-risk populations across all age groups are also expected to drive sustained demand.

Challenges:
Despite their clear safety advantages, the relatively higher cost of smart syringes remains a significant barrier to widespread adoption, particularly in cost-sensitive and developing markets. While basic models may remain competitively priced relative to conventional single-use syringes, advanced versions with enhanced safety features can cost up to five times more, limiting procurement in resource-constrained healthcare systems.

Furthermore, substantial capital investment requirements for manufacturing and maintaining these technologies, combined with pricing variability driven by continuous innovation, constrain market penetration. Over time, increased competition and ongoing technological improvements are expected to alleviate these cost-related challenges.

Regional Trends:
North America is expected to maintain a dominant position in the global smart syringes market, supported by early adoption of advanced healthcare technologies and high awareness of the risks associated with unsafe injection practices. Meanwhile, the Asia-Pacific region is anticipated to exhibit rapid growth, driven by rising investments in healthcare infrastructure, increased public and private sector funding, and a strong emphasis on enhancing clinical safety and operational efficiency.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2010

Recent Developments:
• In July 2022, Sharps Technology acquired the Hungarian syringe manufacturing facility of Safegard Medical for $2.5 Mn. Sharps intended to increase its manufacturing capacity and use the facility to help meet the increasing demand for its smart safety syringes, a market that is projected to reach $14 billion by 2026. The production of intelligent syringes, which are designed to eliminate inadvertent needlestick injuries, prevent needle reuse, and reduce vaccine and medication waste.
• In Mar 2021, Allied Telesis and Terumo Co., Ltd. have collaborated to provide effective location visualisation for medical IoT devices. Terufusion Smart Syringe Pumps were added as wireless devices to the network monitoring and management platform of Allied Telesis Vista Manager EX. On the network map, along with other network and IoT devices, they were then readily identifiable by a syringe pump icon, and their precise location was displayed.

Segmentation of Smart Syringes Market-
By Product-
• With Needle
o Fixed
o Exchangeable
• Without Needle Bioalcohols
By Volume
• Below 1000 μL
• Above 1000 μL
By Application-
• Medical
o Drug Delivery
o Blood Sample Collection
o Vaccination
• Non -Medical use
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/smart-syringes-market/2010

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.